By Sheeba M. | May 13, 2026
Tilray Earnings Beat Signals Cannabis Sector Recovery
Cannabis beverage leader Tilray Brands (TLRY) reported stronger-than-expected Q1 earnings, delivering a 12% revenue beat and posting its second consecutive quarter of positive EBITDA. The results mark a significant inflection point for a sector battered by oversupply and regulatory uncertainty over the past 18 months.
The earnings surprise was driven by three factors: (1) accelerated international expansion into European markets, (2) consolidation of the former Aphria operations delivering 28% cost synergies, and (3) consumer shift toward premium products with higher margin profiles.
What Investors Should Watch
Tilray’s guidance for Q2 suggests 15-18% sequential growth, contingent on three variables: cannabis legalization momentum in Germany (market opens Q4 2025), execution of the planned $200M share buyback, and margin expansion from higher-margin product mix.
The beaten estimates have triggered a rotation into cannabis equities. Curaleaf Holdings (CURLF), the largest U.S. multi-state operator, gained 8.2% on news of Tilray’s beat. Trulieve Cannabis (TRSSF) and Green Thumb Industries (GTBIF) followed with similar upside, suggesting institutional money is returning to the sector.
International Opportunity
Tilray’s European sales grew 34% year-over-year, signaling that investors’ focus is shifting toward jurisdiction-neutral cannabis plays. German legalization—the first G7 nation to move—is expected to create a €4-7B addressable market by 2027. Tilray’s early mover advantage in the region positions it to capture 15-20% market share by 2026.
For traders, the sector’s correlation with U.S. cannabis reform sentiment remains high. Any positive developments on federal rescheduling could trigger another 20-30% rally across MSOs like Curaleaf and AYR Wellness (AYRWF).
Sources
- Reuters — Cannabis market analysis and earnings coverage
- Bloomberg — Financial reporting and regulatory updates
- SEC EDGAR — Official company filings and disclosures
Track cannabis stocks with the Weedstock Real-Time Tracker